Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5375-5375
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Mitochondrial dysfunction: mechanisms and advances in therapy
Zong Yao, Hao Li, Peng Liao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 213
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 143
Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
Raghu Ramanathan, Ahmad H. Ali, Jamal A. Ibdah
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7280-7280
Open Access | Times Cited: 101
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
Youwei Zheng, Shiting Wang, Jialiang Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases
Sisi Chen, Qilong Li, Hanjing Shi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117084-117084
Open Access | Times Cited: 41
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 36
Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
Piero Portincasa, Mohamad Khalil, Laura Mahdi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5640-5640
Open Access | Times Cited: 19
Time to Consider the “Exposome Hypothesis” in the Development of the Obesity Pandemic
Victoria Catalán, Icíar Avilés-Olmos, Amaia Rodrı́guez, et al.
Nutrients (2022) Vol. 14, Iss. 8, pp. 1597-1597
Open Access | Times Cited: 67
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Min Liu, Qiong Huang, Yan Zhu, et al.
Materials Today Bio (2022) Vol. 13, pp. 100215-100215
Open Access | Times Cited: 56
Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis
Chuanfei Zeng, Mingkai Chen
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1079-1079
Open Access | Times Cited: 49
The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome
Mohamad Khalil, Harshitha Shanmugam, Hala Abdallah, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3112-3112
Open Access | Times Cited: 44
Investigating the Link between Ketogenic Diet, NAFLD, Mitochondria, and Oxidative Stress: A Narrative Review
Antonio Paoli, Giuseppe Cerullo
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1065-1065
Open Access | Times Cited: 41
NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
Piero Portincasa
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 993-1006
Open Access | Times Cited: 26
α-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1α/Nrf2 pathway
Danyu Cheng, Mo Zhang, Yezi Zheng, et al.
Redox Biology (2024) Vol. 74, pp. 103230-103230
Open Access | Times Cited: 14
In Silico Analysis of Saroglitazar and Ferulic Acid Binding to Human Ketohexokinase: Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Kalpana Tiwari, Brijesh Kumar, Anurag Tiwari, et al.
Cureus (2025)
Open Access | Times Cited: 1
Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
Pengyu Yao, Yajuan Liu
Molecules (2022) Vol. 28, Iss. 1, pp. 272-272
Open Access | Times Cited: 32
The role of microbiota in nonalcoholic fatty liver disease
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 7
Closed Access | Times Cited: 29
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
Alberto Nascè, Karim Gariani, François R. Jornayvaz, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1131-1131
Open Access | Times Cited: 28
Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity
Carlos Wustemberg Germano, Paulo Ferreira Mega, Thiago Jordão Almeida Prado Mattosinho, et al.
Obesity Surgery (2023) Vol. 33, Iss. 3, pp. 813-820
Closed Access | Times Cited: 22
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
Ying Zhao, Yanni Zhou, Dan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17514-17514
Open Access | Times Cited: 21
Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease
Boyuan Ma, Anji Ju, Shaosen Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 17
Recent advances in age-related metabolic dysfunction-associated steatotic liver disease
Qianjun He, Yifei Li, Ling-Tong Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 652-662
Open Access | Times Cited: 6
Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
Jingqi Xu, Jiayan Shen, Ruolan Yuan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice
Sung‐E Choi, Yoonjung Hwang, Soojin Lee, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 735-747
Closed Access | Times Cited: 23
Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines
Lijuan Xue, Keanqi Liu, Caixia Yan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3545-3560
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top